রেকিটবেন- ৭২৭ মিলিয়ন ডলার দিয়ে যুক্ত করতে যাচ্ছে একটি ফার্মাসিউটিক্যাল

British consumer goods firm Reckitt Benckiser agreed to buy privately-held Indian company Paras Pharmaceuticals for about $726 million, to boost its operations in a fast-growing healthcare market.
Big global healthcare firms are fast driving into emerging markets as sales stall in developed countries and as they look to tap into the healthcare needs of billions of new consumers in places such as China, India, Brazil and Russia.
Paras, which clocked sales of more than 4 billion rupees ($89 million) in the financial year ended March, makes several over-the-counter medications, including Moov pain relief ointment, Krack heel care lotion, and D'Cold cold remedy.
"The research base of companies and the market potential in India are the main attractions for foreign players in the Indian healthcare sector," said R.K. Gupta, managing director at Taurus Asset Management Company in New Delhi.
source